α-Enolase Lies Downstream of mTOR/HIF1α and Promotes Thyroid Carcinoma Progression by Regulating CST1
Novel therapy strategies are crucial for thyroid carcinoma treatment. It is increasingly important to clarify the mechanism of thyroid carcinoma progression. Several studies demonstrate that α-Enolase (ENO1) participates in cancer development; nevertheless, the role of ENO1 in thyroid carcinoma prog...
Main Authors: | Yang Liu, Lida Liao, Changming An, Xiaolei Wang, Zhengjiang Li, Zhengang Xu, Jie Liu, Shaoyan Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.670019/full |
Similar Items
-
HIF-1α Regulates Glucocorticoid-Induced Osteoporosis Through PDK1/AKT/mTOR Signaling Pathway
by: Wen-Ning Xu, et al.
Published: (2020-01-01) -
Effects of NRF-1 and PGC-1α cooperation on HIF-1α and rat cardiomyocyte apoptosis under hypoxia
by: Du, X., et al.
Published: (2022) -
Differential Contribution of N- and C-Terminal Regions of HIF1α and HIF2α to Their Target Gene Selectivity
by: Antonio Bouthelier, et al.
Published: (2020-12-01) -
HIF-1α pathway: role, regulation and intervention for cancer therapy
by: Georgina N. Masoud, et al.
Published: (2015-09-01) -
CST1 Promoted Gastric Cancer Migration and Invasion Through Activating Wnt Pathway
by: Chen S, et al.
Published: (2021-02-01)